SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-21-102495
Filing Date
2021-03-31
Accepted
2021-03-31 17:09:10
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B4 d19910d424b4.htm 424B4 2407122
2 GRAPHIC g19910g04d64.jpg GRAPHIC 38009
3 GRAPHIC g19910g11m86.jpg GRAPHIC 56468
4 GRAPHIC g19910g18q03.jpg GRAPHIC 69198
5 GRAPHIC g19910g26q63.jpg GRAPHIC 99683
6 GRAPHIC g19910g32s63.jpg GRAPHIC 631373
7 GRAPHIC g19910g32w78.jpg GRAPHIC 131527
8 GRAPHIC g19910g34d44.jpg GRAPHIC 90867
9 GRAPHIC g19910g39u54.jpg GRAPHIC 620416
10 GRAPHIC g19910g44w12.jpg GRAPHIC 79629
11 GRAPHIC g19910g50k03.jpg GRAPHIC 37351
12 GRAPHIC g19910g61e40.jpg GRAPHIC 46663
13 GRAPHIC g19910g71l93.jpg GRAPHIC 94926
14 GRAPHIC g19910g96w28.jpg GRAPHIC 605101
15 GRAPHIC g19910g98e91.jpg GRAPHIC 39422
16 GRAPHIC g19910g99t25.jpg GRAPHIC 72972
  Complete submission text file 0001193125-21-102495.txt   6066300
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE X0 SG1 2FX 44 (0) 1438 906855
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-253735 | Film No.: 21794490
SIC: 2836 Biological Products, (No Diagnostic Substances)